High Net Worth Advisory Group’s CVS Health CVS Stock Holding History

High Net Worth Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,550	Closed	-$203K	–	220
2024 Q1	$203K	Buy	+2,550	New	+$195K	0.06%	210
2023 Q4	–	Sell	-2,920	Closed	-$204K	–	200
2023 Q3	$204K	Sell	2,920 -1,200	-29%	-$85K	0.08%	184
2023 Q2	$285K	Sell	4,120 -610	-13%	-$43.4K	0.11%	149
2023 Q1	$351K	Sell	4,730 -149	-3%	-$12.5K	0.14%	131
2022 Q4	$455K	Buy	4,879 +125	+3%	+$12.1K	0.18%	114
2022 Q3	$453K	Hold	4,754	–	–	0.19%	107
2022 Q2	$441K	Sell	4,754 -51	-1%	-$4.98K	0.18%	112
2022 Q1	$486K	Sell	4,805 -161	-3%	-$16.9K	0.18%	109
2021 Q4	$512K	Buy	+4,966	New	+$459K	0.18%	110

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

High Net Worth Advisory Group's CVS Position: Q2 2024 in Review

High Net Worth Advisory Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,550 shares — an estimated $203K sold.

High Net Worth Advisory Group first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $512K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

High Net Worth Advisory Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
High Net Worth Advisory Group sold 2,550 CVS Health shares in Q2 2024, an estimated $203K.
High Net Worth Advisory Group first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
High Net Worth Advisory Group's CVS Health position peaked at $512K in Q4 2021.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on High Net Worth Advisory Group's 13F filing for Q2 2024, filed 17 Jul 2024.